Joseph C. Marini

Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: Implications for the treatment of multiple sclerosis

D. Craig Hooper, Omar Bagasra, Joseph C. Marini et al. · Proceedings of the National Academy of Sciences · 1997 · 333 citations · Full text

Life Sciences, Neurology, Neuroscience +15

Pharmacokinetics and Safety of Golimumab, a Fully Human Anti‐TNF‐α Monoclonal Antibody, in Subjects With Rheumatoid Arthritis

Honghui Zhou, Haishan Jang, Roy Fleischmann et al. · The Journal of Clinical Pharmacology · 2007 · 194 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Population Pharmacokinetic Modeling of Ustekinumab, a Human Monoclonal Antibody Targeting IL‐12/23p40, in Patients With Moderate to Severe Plaque Psoriasis

Yaowei Zhu, Chuanpu Hu, Ming Lu et al. · The Journal of Clinical Pharmacology · 2009 · 167 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

New Genetic Loci That Control Susceptibility and Symptoms of Experimental Allergic Encephalomyelitis in Inbred Mice

Russell J. Butterfield, Jayce Sudweeks, Elizabeth P. Blankenhorn et al. · The Journal of Immunology · 1998 · 154 citations · Full text

Life Sciences, Genetics, Immunology +16

Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab

Sudha Visvanathan, Carrie Wagner, Joseph C. Marini et al. · Annals of the Rheumatic Diseases · 2007 · 151 citations · Full text

Medicine, Immunology, Immunopathology +16